NAD+ & SAM Pathway Studies Published research uses NNMT inhibitors to investigate downstream effects on nicotinamide adenine dinucleotide (NAD+) availability and S-adenosylmethionine (SAM)-dependent methylation reactions in cultured cells and animal models
The effectiveness of once-daily subcutaneous liraglutide administration for weight loss management in adults was established in five large-scale randomized multicentre phase 3 trials [49,50,51,52,53], four of which were part of the SCALE program (Satiety and Clinical AdiposityLiraglutide Evidence in nondiabetic and diabetic individuals), leading to its approval at a dose of 3.0 mg subcutaneous once-daily (weekly increased from 0.6 mg to 3 mg/day)
Details of the work were published in 2014
In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved
10.1001/jamanetworkopen.2022.19661 22 KatoM.TakadaS.KashidaY.NomuraM
If you don't see results after 4 to 8 weeks, it could be due to low bioavailability (using standard pills instead of liposomal forms) or a high "toxic load" that is depleting your levels as fast as you can replenish them